Defining the Problem Hypertension (HTN) is a critical public health issue and a leading risk factor for cardiovascular disease (CVD) and stroke, driving significant global morbidity and mortality (GBD 2017 Causes of Death Collaborators, 2018; Mills, Stefanescu, & He, 2020). The relationship between HTN and CVD is well documented, as elevated blood pressure damages arterial walls, leading to heart failure if untreated (American Heart Association, 2023). In the United States, nearly half of adults, or about 47%, are affected by HTN or rely on medication to manage it (Centers for Disease Control and Prevention, 2019). The economic impact is profound; HTN is the most costly aspect of CVD, with expenses stemming from hospitalizations, medications, and reduced productivity (Heidenreich et al., 2011).